
11 - 50 employees
Founded 2018
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
Biotechnology • Pharmaceuticals
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics based on its RBP4 (Retinol Binding Protein 4) intellectual property portfolio. Its lead candidate, tinlarebant (LBS-008), is an oral therapy designed to reduce toxic accumulations in the eye and is being developed for retinal degenerative diseases including autosomal recessive Stargardt disease (STGD1) and Geographic Atrophy (advanced dry age-related macular degeneration). Belite Bio is conducting multiple clinical trials (Phase 1b/2, Phase 2/3, and Phase 3 programs such as DRAGON, DRAGON II, and PHOENIX) and tinlarebant has received several regulatory designations (Orphan Drug in US/EU/Japan, Rare Pediatric Disease, Breakthrough Therapy, Fast Track, and Sakigake). The company’s pipeline also includes programs addressing metabolic and liver diseases (e. g. , non-alcoholic fatty liver disease and type 2 diabetes).
🔥 2 minutes ago
Where this job comes from
Posted on Belite Bio's careers page, not through a job board
First seen by Remote Rocketship 2 minutes ago

11 - 50 employees
Founded 2018
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $402M Post-IPO Equity on 2025-12
Biotechnology • Pharmaceuticals
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics based on its RBP4 (Retinol Binding Protein 4) intellectual property portfolio. Its lead candidate, tinlarebant (LBS-008), is an oral therapy designed to reduce toxic accumulations in the eye and is being developed for retinal degenerative diseases including autosomal recessive Stargardt disease (STGD1) and Geographic Atrophy (advanced dry age-related macular degeneration). Belite Bio is conducting multiple clinical trials (Phase 1b/2, Phase 2/3, and Phase 3 programs such as DRAGON, DRAGON II, and PHOENIX) and tinlarebant has received several regulatory designations (Orphan Drug in US/EU/Japan, Rare Pediatric Disease, Breakthrough Therapy, Fast Track, and Sakigake). The company’s pipeline also includes programs addressing metabolic and liver diseases (e. g. , non-alcoholic fatty liver disease and type 2 diabetes).
• Recruit, hire, onboard, and develop a high-performing team of Territory Business Managers across an assigned region • Lead the team through pre-launch training, planning, and market development • Translate national brand strategy into a regional business plan • Set territory-level strategy and tactical plans while holding TBMs accountable to activity, access, and sales objectives • Spend approximately 50-60% of field time co-traveling with TBMs and provide actionable coaching • Partner with Marketing, Market Access, Medical Affairs, Patient Services, Regulatory, and Legal/Compliance • Manage regional budget, expenses, and resource allocation • Foster customer prioritization, thoughtful resource allocation, and analytical opportunity assessment • Monitor and report lead/lag indicators and escalate competitive intelligence and field insights to sales leadership • Ensure compliance with FDA promotional regulations, PhRMA Code, and company policies • Represent Belite Bio at regional and national IRD/retina conferences and advocacy events • Foster collaboration, innovation, creativity, development, and accountability
• Bachelor's degree required; advanced degree a plus • 8+ years of pharmaceutical, biotech, or medical device sales experience • 5+ years of direct sales management/first-line leadership experience • Ophthalmology, retina, or rare/orphan disease experience strongly preferred • Specialty pharmacy experience is a plus • Demonstrated success building or rebuilding a team, including hiring in a competitive talent market and developing representatives in low-incidence, rare disease selling environments • Prior product launch experience, ideally in a small or pre-commercial biopharma setting • Strong understanding of the payer/reimbursement landscape including hub services and patient access support models • Ability to build relationships with academic and community retina specialists, genetic counselors, and low-vision/ancillary care providers relevant to the IRD patient journey • Exceptional coaching, communication, and cross-functional collaboration skills • High integrity and comfort operating in a compliance-forward culture • Willingness and ability to travel 50-60% of the time, including overnights, internal meetings, field time, and conventions • Must reside within a 60-minute drive of a major commercial airport • Must be authorized to work in the United States
• Performance-based incentives • Comprehensive health and wellness benefits • 401(k)-retirement plan with company match • Paid time off • Professional development opportunities
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 16 minutes ago
Director developing project-management leaders for NTI, a fiber-optic and data-center infrastructure installer. Building onboarding, competency, coaching, and readiness programs across project-management levels.
🔥 16 minutes ago
Commercial programs director building Andrenam’s maritime sensing sales pipeline. Developing verticals, partnerships, pilots, and production contracts with commercial maritime buyers.
🔥 16 minutes ago
Director building Andrenam’s government capture pipeline for maritime sensing systems. Winning DoD, USCG, and DHS programs through acquisition expertise and agency relationships.
🔥 19 minutes ago
Director of Product Management leading GolfNow’s B2B golf technology portfolio at VERSANT. Developing Product Managers and driving customer adoption, operational efficiency, and commercial growth.
🔥 40 minutes ago
Customer Strategy Director rebuilding lifecycle operations, KPI infrastructure, and technical enablement. Driving customer success transformation for Arcadia’s AI-powered energy intelligence platform.